Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.

Future Trends in Proteins To Fight COVID-19

Share this article

The global scientific community's attention has turned to COVID-19, a pandemic that has swept across the world since emerging in China in late December 2019. The future is now.

The causative agent of COVID-19, the coronavirus SARS-CoV-2, has no vaccine, and no biologics or small molecules have yet been approved to treat it. There is a big opportunity for protein engineering to make an impact on this disease without a cure.

This whitepaper examines the current challenges and opportunities in developing protein therapeutics to treat COVID-19, looking at existing case studies across preclinical development, targeting and regulatory approval.

To read the whitepaper, just click on the image below. 

Future trends in proteins to fight COVID-19

Have any questions about the report or interested in sponsoring a future whitepaper? Email andrew.burrows@informa.com.

Share this article

Upcoming event

Antibody Engineering & Therapeutics US

14 - 16 Dec 2020, Delivered in Eastern Standard Time (EST)
THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS
Go to site